Author: Patel, M.; Gangemi, A.; Marron, R.; Chowdhury, J.; Yousef, I.; Zheng, M.; Mills, N.; Tragesser, L.; Giurintano, J.; Gupta, R.; Gordon, M.; Rali, P.; D'Alonzo, G.; Fleece, D.; Zhao, H.; Patlakh, N.; Criner, G. J.
Title: Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19 Cord-id: wc23tqv2 Document date: 2020_5_26
ID: wc23tqv2
Snippet: Abstract Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of High flow nasal therapy (HFNT) has been greatly debated around the world for use in COVID-19 pandemic due to concern for increased healthcare worker transmission. Methods This was a retrospective analysis of consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to April 24, 2020 with moderate to severe respiratory failure treated with
Document: Abstract Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of High flow nasal therapy (HFNT) has been greatly debated around the world for use in COVID-19 pandemic due to concern for increased healthcare worker transmission. Methods This was a retrospective analysis of consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to April 24, 2020 with moderate to severe respiratory failure treated with High Flow nasal therapy (HFNT). Primary outcome was prevention of intubation. Results Of the 445 patients with COVID-19, 104 met our inclusion criteria. The average age was 60.66 (+13.50) years, 49 (47.12 %) were female, 53 (50.96%) were African American, 23 (22.12%) Hispanic. Forty-three patients (43.43%) were smokers. SF and chest Xray scores had a statistically significant improvement from day 1 to day 7. 67 of 104 (64.42%) were able to avoid invasive mechanical ventilation in our cohort. Incidence of hospital/ventilator associated pneumonia was 2.9%. Overall, mortality was 14.44% (n=15) in our cohort with 13 (34.4%) in the progressed to intubation group and 2 (2.9%) in the non-intubation group. Mortality and incidence of VAP/HAP was statistically higher in the progressed to intubation group. Conclusion HFNT use is associated with a reduction in the rate of Invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.
Search related documents:
Co phrase search for related documents- acute hypoxemic respiratory failure and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
- acute hypoxemic respiratory failure and los stay hospital length: 1, 2, 3
- acute respiratory illness and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory illness and los stay hospital length: 1
- acute respiratory syndrome sars and adjust association: 1
- acute respiratory syndrome sars and admission laboratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome sars and log rank test compare: 1
- acute respiratory syndrome sars and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome sars and los stay hospital length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adequate calibration and logistic regression: 1, 2
- adequate calibration and los stay hospital length: 1
- adjust association and logistic regression: 1, 2, 3, 4
- admission laboratory and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- admission laboratory and los stay hospital length: 1, 2, 3, 4, 5
- log rank test compare and logistic regression: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date